A subsidiary of GL Rapha company will start producing the Russian coronavirus vaccine Sрutnik V in the Republic of Korea in May, Yonhap news agency reports on Tuesday.

Axar.az reports that the Russian Direct Investment Fund (RDIF) initially negotiated production of 150 mln vaccine doses with GL Rapha and RDIF later made an agreement to produce 500 mln doses more with the consortium headed by this Korean company. All the volumes will be exported, the agency says. The Russian vaccine has not yet been approved in the country.

On April 15, RDIF informed that it signed the technology transfer agreement with the consortium. The pilot batch of vaccine has already been handed over to the Russian side.

An agreement with the consortium headed by Huons Global was made on April 16. Production volumes were not disclosed but the consortium is able to produce about 100 mln doses per month%.